期刊文献+

葡萄糖转运蛋白1与慢性病关联机制的研究进展 被引量:1

The research progress about the mechanisms of glucose transporter GLUT1 associated with chronic diseases
原文传递
导出
摘要 葡萄糖转运蛋白1(glucose tansporter 1,GLUT1)由SLC2A1基因编码,调控不同细胞从多个组织摄取葡萄糖的能力。慢性病是当今人类死亡的第一主因,发病原因与人体内环境紊乱、代谢异常、环境污染相关。GLUT1作为最先被发现的葡萄糖转运蛋白家族成员,对慢性病的调控起到至关重要作用。本文针对GLUT1蛋白的生物学结构和功能及其与慢性病如糖尿病及其并发症、慢性炎症和肿瘤的关联机制进行探讨,试图找到以GLUT1蛋白介导的信号通路治疗慢性病的相关分子机制和有效方案。 Glucose tansporter 1 is encoded by SLC2A1 gene, regulating the function of different cells to take in glucose from different tissues. Chronic disease is the first cause of human death. And it's pathogenesis is associated with internal environment disorder, metabolic abnormality and environmental pollution. GLUT1 was the first member of the family of glucose transporters to be found, which plays an important role in the regulation of chronic diseases. Therefore our review focuses on the biological structure and function of GLUT1, and keeping an insight in the associated mechanisms between GLUT1 biological function and the chronic diseases, including diabetes and its complications, chronic inflammation and cancer. We try to find related molecular mechanisms and effective programs of treating chronic diseases with GLUT1 protein mediated signaling pathway.
作者 沈文清 孙易 漆正堂 丁树哲 SHEN Wenqing;SUN Yi;QI Zhengtang;DING Shuzhe(Department of Physical Education and Health,East China Normal University,Shanghai 200241,China;Adolescent Health Assessment and Exercise Intervention" Key Laboratory of Ministry of Education,Shanghai 200241,China)
出处 《生命的化学》 CAS CSCD 2018年第4期595-602,共8页 Chemistry of Life
基金 国家自然科学基金项目(31671241)
关键词 葡萄糖转运蛋白 GLUT1 慢性病 糖尿病 肿瘤 关联机制 glucose transporter GLUT 1 chronic diseases diabetes cancer associated mechanisms
  • 相关文献

参考文献6

二级参考文献49

  • 1Marta Villarroel,Andreea Ciudin,Cristina Hernández,Rafael Simó.Neurodegeneration:An early event of diabetic retinopathy[J].World Journal of Diabetes,2010,1(2):57-64. 被引量:43
  • 2BURG D, FILIPPOV D V, HERINANNS R, et al. Peptidoiniinetic glutathione analogues as novel gainina GT stable GST inhititors[J]. Bio Med Chem, 2002, 10( 1 ) : 195-205.
  • 3YOUNG L C, CAMPLING B G, COLE SP, et al. Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels[J]. Clin Cancer Res, 2001,7(6): 1798-1804.
  • 4KIM J, LEE H S, BAE S I, et al. Silencing and CpG island methylation of GSTP1 is rare in ordinary gastric carcinomas but common in Epstein-Barr virus-associated gastric carcinomas [ J ].Anticancer Res, 2005, 25(6B) : 4013-4019.
  • 5WARTENBERG M, LING F C, MUSCHEN M, et al. Regulation of the multidrug resistance transporter P-glycoprotein in multicellular tumor spheroids by hypoxia-inducible factor ( HIF-1 ) and reactive oxygen species [ J ]. FEBS Lett,2005, 579 ( 20 ) : 4541-4549.
  • 6COMERFORD K M, WALLACE TJ, KARHAUSEN J,et al. Hypoxia-inducible factor-1-dependent regulation of the muhidrug resistance ( MDR1 ) gene[ J ]. Cancer Res, 2002, 62 (12) : 3387- 3394.
  • 7CANTUARIA G, FAGOTFI A, FWRRANDINA G, et al. GLUT- 1 expression in ovarian carcinoma: association with survival and response to chemotherapy [ J ]. Cancer, 2001, 92 ( 5 ) : 1144- 1150.
  • 8SOBIN L H, WITrEKIND C. UICC TNM classification of malignant tumous[ M]. 5 thed. New York : Wiley Liss , 1997:93-97.
  • 9SEMENZA G L. HIF-1 : mediator of physiological and pathophysiological responses to hypoxia[J]. J Appl Physiol, 2000, 88(4) : 1474-1480.
  • 10JEWELL U R, KVIETIKOVA I, SCHEID A, et al. Induction of HIF-1α in response to hypoxia is instantaneous [ J ]. FASEB J, 2001, 15(7) :1312-1314.

共引文献52

同被引文献18

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部